Login / Signup
High-dose romiplostim accelerates hematologic recovery in patients with aplastic anemia refractory to eltrombopag.
Kohei Hosokawa
Hirohito Yamazaki
Mikoto Tanabe
Tatsuya Imi
Naomi Sugimori
Shinji Nakao
Published in:
Leukemia (2020)
Keyphrases
</>
high dose
stem cell transplantation
low dose
chronic kidney disease
iron deficiency
allogeneic hematopoietic stem cell transplantation
acute lymphoblastic leukemia